Literature DB >> 18557298

Decontamination of multiple casualties who are chemically contaminated: a challenge for acute hospitals.

Simon F J Clarke1, Rob P Chilcott, James C Wilson, Robie Kamanyire, David J Baker, Anthony Hallett.   

Abstract

Patients who have been contaminated by chemical compounds present a number of difficulties to emergency departments, in particular, the risk of secondary contamination of healthcare staff and facilities. The Department of Health in the United Kingdom has provided equipment to decontaminate chemically contaminated casualties who present at emergency departments. The capacity of this equipment is limited, and although both the ambulance and fire services have equipment to cope with mass casualties at the scene of a chemical incident, there is still the possibility that acute hospitals will be overwhelmed by large numbers of self-presenting patients. The risks and potential consequences of this gap in resilience are discussed and a number of possible practical solutions are proposed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557298     DOI: 10.1017/s1049023x00005811

Source DB:  PubMed          Journal:  Prehosp Disaster Med        ISSN: 1049-023X            Impact factor:   2.040


  3 in total

1.  Chemical warfare agents.

Authors:  K Ganesan; S K Raza; R Vijayaraghavan
Journal:  J Pharm Bioallied Sci       Date:  2010-07

2.  Mass Casualty Decontamination in a Chemical or Radiological/Nuclear Incident with External Contamination: Guiding Principles and Research Needs.

Authors:  Susan M Cibulsky; Danny Sokolowski; Marc Lafontaine; Christine Gagnon; Peter G Blain; David Russell; Helmut Kreppel; Walter Biederbick; Takeshi Shimazu; Hisayoshi Kondo; Tomoya Saito; Jean-René Jourdain; Francois Paquet; Chunsheng Li; Makoto Akashi; Hideo Tatsuzaki; Lesley Prosser
Journal:  PLoS Curr       Date:  2015-11-02

3.  Preparedness lessons from modern disasters and wars.

Authors:  Saqib I Dara; J Christopher Farmer
Journal:  Crit Care Clin       Date:  2009-01       Impact factor: 3.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.